| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yanhui Chen, Zhongling Ke, Ying Ouyang, Ying Han, Dong Liang, Xueping Gao, Jie He, Yasong D. Clonidine Patch for Tourette Syndrome With Attention-Deficit/Hyperactivity Disorder. Psychiatry investigation. vol 21. issue 4. 2024-05-02. PMID:38695046. |
clonidine patch for tourette syndrome with attention-deficit/hyperactivity disorder. |
2024-05-02 |
2024-05-04 |
Not clear |
| Yanhui Chen, Zhongling Ke, Ying Ouyang, Ying Han, Dong Liang, Xueping Gao, Jie He, Yasong D. Clonidine Patch for Tourette Syndrome With Attention-Deficit/Hyperactivity Disorder. Psychiatry investigation. vol 21. issue 4. 2024-05-02. PMID:38695046. |
to explore the efficacy and safety of clonidine adhesive patch in tourette syndrome (ts) patients with comorbid attentiondeficit/hyperactivity disorder (adhd). |
2024-05-02 |
2024-05-04 |
Not clear |
| Melanie Turne. The role of drugs in the treatment of autism. Australian prescriber. vol 43. issue 6. 2021-02-04. PMID:33363299. |
clonidine is first line for children with tourette syndrome. |
2021-02-04 |
2023-08-13 |
Not clear |
| Charlotte Spay, Marion Albares, Guillaume Lio, Stephane Thobois, Emmanuel Broussolle, Brian Lau, Benedicte Ballanger, Philippe Boulingue. Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients. Journal of neurochemistry. vol 146. issue 3. 2019-06-26. PMID:29675956. |
as the noradrenergic system is likely to support cognitive functions including attention and executive control, other clinical uses of clonidine have recently gained popularity for the treatment of neuropsychiatric disorders like attention-deficit hyperactivity disorder or tourette syndrome, but the mechanism of action is still unclear. |
2019-06-26 |
2023-08-13 |
Not clear |
| Andreia Corciov. Validated Colorimetric Assay of Clonidine Hydrochloride from Pharmaceutical Preparations. Iranian journal of pharmaceutical research : IJPR. vol 15. issue 1. 2016-09-09. PMID:27610155. |
clonidine hydrochloride is an antihypertensive agent used for migraine prophylaxis, attention deficit hyperactivity disorder, menopausal flushing and tourette syndrome. |
2016-09-09 |
2023-08-13 |
Not clear |
| Fuyong Jiao, Xiaoyan Zhang, Xipin Zhang, Jing Wan. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 20. issue 1. 2016-07-29. PMID:26602699. |
clinical observation on treatment of tourette syndrome in chinese children by clonidine adhesive patch. |
2016-07-29 |
2023-08-13 |
Not clear |
| Fuyong Jiao, Xiaoyan Zhang, Xipin Zhang, Jing Wan. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 20. issue 1. 2016-07-29. PMID:26602699. |
to evaluate the therapeutic effectiveness and safety of clonidine adhesive patch in treating tourette syndrome (ts). |
2016-07-29 |
2023-08-13 |
Not clear |
| Valsamma Eapen, Philip Ward, Raymond Clark. Clonidine in Tourette syndrome and sensorimotor gating. Psychiatry research. vol 215. issue 2. 2014-12-03. PMID:24210663. |
clonidine in tourette syndrome and sensorimotor gating. |
2014-12-03 |
2023-08-12 |
Not clear |
| Andrea Eugenio Cavanna, Claudia Selvini, Cristiano Termine, Umberto Balottin, Clare M Edd. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome. Clinical neuropharmacology. vol 35. issue 6. 2013-08-26. PMID:23123691. |
tolerability profile of clonidine in the treatment of adults with tourette syndrome. |
2013-08-26 |
2023-08-12 |
Not clear |
| Andrea Eugenio Cavanna, Claudia Selvini, Cristiano Termine, Umberto Balottin, Clare M Edd. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome. Clinical neuropharmacology. vol 35. issue 6. 2013-08-26. PMID:23123691. |
clonidine, an alpha-2 adrenergic agonist, has been used to treat tourette syndrome (ts) for nearly 3 decades. |
2013-08-26 |
2023-08-12 |
Not clear |
| Isurima Katuwawela, Andrea E Cavann. Good response to clonidine in tourette syndrome associated with chromosomal translocation involving the IMMP2L gene. The Journal of neuropsychiatry and clinical neurosciences. vol 24. issue 1. 2012-08-08. PMID:22450629. |
good response to clonidine in tourette syndrome associated with chromosomal translocation involving the immp2l gene. |
2012-08-08 |
2023-08-12 |
Not clear |
| Ebrahim Kantini, Helen J Cassaday, Chris Hollis, Georgina M Jackso. The Normal Inhibition of Associations is Impaired by Clonidine in Tourette Syndrome. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 20. issue 2. 2011-07-14. PMID:21541098. |
the normal inhibition of associations is impaired by clonidine in tourette syndrome. |
2011-07-14 |
2023-08-12 |
Not clear |
| Erika F Hedderick, Christina M Morris, Harvey S Singe. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatric neurology. vol 40. issue 6. 2009-08-10. PMID:19433274. |
double-blind, crossover study of clonidine and levetiracetam in tourette syndrome. |
2009-08-10 |
2023-08-12 |
human |
| Erika F Hedderick, Christina M Morris, Harvey S Singe. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatric neurology. vol 40. issue 6. 2009-08-10. PMID:19433274. |
we compared the efficacy of clonidine and levetiracetam for treating tics in tourette syndrome. |
2009-08-10 |
2023-08-12 |
human |
| Neal R Swerdlow, Michele J Bongiovanni, Laura Tochen, Jody M Shoemake. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology. vol 186. issue 2. 2006-10-20. PMID:16583235. |
the hypothesis that ppi may be regulated by norepinephrine, or by interactions between dopamine and norepinephrine substrates, was tested in a series of experiments with the alpha-2 agonist, clonidine, which is used clinically to treat tourette syndrome (ts). |
2006-10-20 |
2023-08-12 |
rat |
| . Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. vol 58. issue 4. 2002-04-15. PMID:11865128. |
the treatment of children with attention deficit hyperactivity disorder (adhd) and tourette syndrome (ts) has been problematic because methylphenidate (mph)--the most commonly used drug to treat adhd--has been reported to worsen tics and because clonidine (clon)--the most commonly prescribed alternative--has unproven efficacy. |
2002-04-15 |
2023-08-12 |
Not clear |
| A R Kessle. Clonidine treatment increases tics in patients with Tourette syndrome: case report. Journal of child neurology. vol 16. issue 5. 2001-12-07. PMID:11392527. |
clonidine usually serves as a tic-suppressing agent in patients with tourette syndrome. |
2001-12-07 |
2023-08-12 |
Not clear |
| A R Kessle. Clonidine treatment increases tics in patients with Tourette syndrome: case report. Journal of child neurology. vol 16. issue 5. 2001-12-07. PMID:11392527. |
clonidine treatment increases tics in patients with tourette syndrome: case report. |
2001-12-07 |
2023-08-12 |
Not clear |
| D G Lichter, L A Jackso. Predictors of clonidine response in Tourette syndrome: implications and inferences. Journal of child neurology. vol 11. issue 2. 1996-12-17. PMID:8881983. |
the findings (1) provide indirect support for involvement of central noradrenergic systems in tic expression; (2) suggest that emergence of a tic-related neurophysiologic dysfunction may be necessary for optimal behavioral response to clonidine in tourette syndrome; and (3) provide broad guidelines for the clinician considering clonidine therapy for pediatric patients with tourette syndrome, particularly those with comorbid attention-deficit hyperactivity disorder. |
1996-12-17 |
2023-08-12 |
human |
| D G Lichter, L A Jackso. Predictors of clonidine response in Tourette syndrome: implications and inferences. Journal of child neurology. vol 11. issue 2. 1996-12-17. PMID:8881983. |
clonidine is an alpha-adrenergic agonist which may alleviate emerging symptoms in tourette syndrome, an observation that has fueled speculation regarding involvement of stress-sensitive central noradrenergic systems in this disorder. |
1996-12-17 |
2023-08-12 |
human |